FY 2025 Results

Ipsen FY 2025 Results Call

The Ipsen FY 2025 Results Call will take place on February 12th, from 2:00 to 3:00pm CET.

About Ipsen

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.

Our pipeline is fueled by internal and external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries, and our partnerships around the world, enable us to bring medicines to patients in more than 100 countries.

Latest results and presentation

Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance

– 22 October 2025 – 1 mins read

22 October 2025 – 1 mins read

Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance

PARIS, FRANCE, 22 October 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the year to date and the third quarter of 2025.

If you are experiencing difficulties registering for the investor and analyst conference call, please contact: khalid.deojee@ipsen.com